CO5590896A2 - Compuestos quimicos - Google Patents
Compuestos quimicosInfo
- Publication number
- CO5590896A2 CO5590896A2 CO04057414A CO04057414A CO5590896A2 CO 5590896 A2 CO5590896 A2 CO 5590896A2 CO 04057414 A CO04057414 A CO 04057414A CO 04057414 A CO04057414 A CO 04057414A CO 5590896 A2 CO5590896 A2 CO 5590896A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- nrarb
- 4alkyl
- ord
- nrc
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229910003827 NRaRb Inorganic materials 0.000 abstract 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000002367 halogens Chemical group 0.000 abstract 4
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 101150008103 hal gene Proteins 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0130705.7A GB0130705D0 (en) | 2001-12-21 | 2001-12-21 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5590896A2 true CO5590896A2 (es) | 2005-12-30 |
Family
ID=9928210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO04057414A CO5590896A2 (es) | 2001-12-21 | 2004-06-18 | Compuestos quimicos |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20050059726A1 (https=) |
| EP (1) | EP1456172A1 (https=) |
| JP (1) | JP2005519885A (https=) |
| KR (1) | KR20040072666A (https=) |
| CN (1) | CN100364971C (https=) |
| AR (1) | AR037928A1 (https=) |
| AU (1) | AU2002366747A1 (https=) |
| BR (1) | BR0215200A (https=) |
| CA (1) | CA2471461A1 (https=) |
| CO (1) | CO5590896A2 (https=) |
| GB (1) | GB0130705D0 (https=) |
| HU (1) | HUP0500137A2 (https=) |
| IL (1) | IL162454A0 (https=) |
| IS (1) | IS7316A (https=) |
| MX (1) | MXPA04006139A (https=) |
| MY (1) | MY141579A (https=) |
| NO (1) | NO20042990L (https=) |
| NZ (1) | NZ533129A (https=) |
| PL (1) | PL371008A1 (https=) |
| RU (1) | RU2318807C2 (https=) |
| TW (1) | TWI262075B (https=) |
| WO (1) | WO2003053925A1 (https=) |
| ZA (1) | ZA200404147B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200307667A (en) | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| GB0314299D0 (en) * | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| GB0314373D0 (en) * | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| EP1641752A1 (en) | 2003-06-19 | 2006-04-05 | Glaxo Group Limited | 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa |
| GB0314370D0 (en) * | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| US7169795B2 (en) | 2003-09-30 | 2007-01-30 | Bristol Myers Squibb Company | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| US7381728B2 (en) | 2004-07-28 | 2008-06-03 | Glaxo Group Limited | Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| DE102004062544A1 (de) | 2004-12-24 | 2006-07-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel |
| DE102005008649A1 (de) | 2005-02-25 | 2006-09-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Pyrrolidinone, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1869010A1 (en) * | 2005-04-11 | 2007-12-26 | Glaxo Group Limited | 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors |
| WO2006137527A1 (ja) | 2005-06-23 | 2006-12-28 | Kyowa Hakko Kogyo Co., Ltd. | チアゾール誘導体 |
| DK1921077T3 (en) | 2005-08-02 | 2017-10-23 | Kyowa Hakko Kirin Co Ltd | Means for treating and / or preventing sleep disorders |
| US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
| JP2009517351A (ja) * | 2005-11-24 | 2009-04-30 | グラクソ グループ リミテッド | 化学物質 |
| DK2012839T3 (da) | 2006-04-07 | 2012-04-10 | Bactiguard Ab | Hidtil ukendte antimikrobielle substrater og anvendelser deraf |
| KR20090053923A (ko) * | 2006-09-22 | 2009-05-28 | 노파르티스 아게 | 헤테로시클릭 유기 화합물 |
| CN116003280B (zh) * | 2022-12-30 | 2024-11-19 | 合肥工业大学 | 一种芳基甲酰胺类化合物的光化学合成方法 |
| CN116712596A (zh) * | 2023-05-30 | 2023-09-08 | 北京福爱乐科技发展有限公司 | 一种用于体内创面喷涂型医用胶及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202344A (en) * | 1990-12-11 | 1993-04-13 | G. D. Searle & Co. | N-substituted lactams useful as cholecystokinin antagonists |
| SI9520044B (sl) * | 1994-04-26 | 2004-08-31 | Aventis Pharmaceuticals Inc. | Inhibitorji Xa faktorja |
| US6034093A (en) * | 1995-06-07 | 2000-03-07 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| US5731315A (en) * | 1995-06-07 | 1998-03-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds |
| AU4064597A (en) * | 1996-08-16 | 1998-03-06 | Du Pont Pharmaceuticals Company | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| GB9715894D0 (en) * | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic derivatives |
| US6403632B1 (en) * | 2000-03-01 | 2002-06-11 | Bristol Myers Squibb Pharma Co | Lactam metalloprotease inhibitors |
| US6025358A (en) * | 1998-06-11 | 2000-02-15 | G. D. Searle & Co. | Double prodrugs of potent GP IIb/IIIa antagonists |
| GB0114005D0 (en) * | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| TW200307667A (en) * | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| US7169795B2 (en) * | 2003-09-30 | 2007-01-30 | Bristol Myers Squibb Company | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
-
2001
- 2001-12-21 GB GBGB0130705.7A patent/GB0130705D0/en not_active Ceased
-
2002
- 2002-12-19 TW TW091136597A patent/TWI262075B/zh not_active IP Right Cessation
- 2002-12-19 AR ARP020105014A patent/AR037928A1/es not_active Application Discontinuation
- 2002-12-19 MY MYPI20024789A patent/MY141579A/en unknown
- 2002-12-20 AU AU2002366747A patent/AU2002366747A1/en not_active Abandoned
- 2002-12-20 CA CA002471461A patent/CA2471461A1/en not_active Abandoned
- 2002-12-20 BR BR0215200-2A patent/BR0215200A/pt not_active IP Right Cessation
- 2002-12-20 RU RU2004122427/04A patent/RU2318807C2/ru not_active IP Right Cessation
- 2002-12-20 WO PCT/EP2002/014826 patent/WO2003053925A1/en not_active Ceased
- 2002-12-20 JP JP2003554642A patent/JP2005519885A/ja active Pending
- 2002-12-20 MX MXPA04006139A patent/MXPA04006139A/es active IP Right Grant
- 2002-12-20 US US10/499,529 patent/US20050059726A1/en not_active Abandoned
- 2002-12-20 NZ NZ533129A patent/NZ533129A/en unknown
- 2002-12-20 IL IL16245402A patent/IL162454A0/xx unknown
- 2002-12-20 HU HU0500137A patent/HUP0500137A2/hu unknown
- 2002-12-20 KR KR10-2004-7009675A patent/KR20040072666A/ko not_active Ceased
- 2002-12-20 PL PL02371008A patent/PL371008A1/xx not_active Application Discontinuation
- 2002-12-20 EP EP02805350A patent/EP1456172A1/en not_active Withdrawn
- 2002-12-20 CN CNB028282248A patent/CN100364971C/zh not_active Expired - Fee Related
-
2004
- 2004-05-27 ZA ZA200404147A patent/ZA200404147B/en unknown
- 2004-06-16 IS IS7316A patent/IS7316A/is unknown
- 2004-06-18 CO CO04057414A patent/CO5590896A2/es not_active Application Discontinuation
- 2004-07-13 NO NO20042990A patent/NO20042990L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003053925A1 (en) | 2003-07-03 |
| US20050059726A1 (en) | 2005-03-17 |
| JP2005519885A (ja) | 2005-07-07 |
| MXPA04006139A (es) | 2004-11-01 |
| TWI262075B (en) | 2006-09-21 |
| IL162454A0 (en) | 2005-11-20 |
| GB0130705D0 (en) | 2002-02-06 |
| NZ533129A (en) | 2006-12-22 |
| EP1456172A1 (en) | 2004-09-15 |
| CA2471461A1 (en) | 2003-07-03 |
| KR20040072666A (ko) | 2004-08-18 |
| CN100364971C (zh) | 2008-01-30 |
| AU2002366747A1 (en) | 2003-07-09 |
| IS7316A (is) | 2004-06-16 |
| RU2004122427A (ru) | 2006-01-20 |
| HUP0500137A2 (en) | 2006-02-28 |
| NO20042990L (no) | 2004-09-20 |
| AR037928A1 (es) | 2004-12-22 |
| CN1620434A (zh) | 2005-05-25 |
| BR0215200A (pt) | 2004-10-13 |
| PL371008A1 (en) | 2005-06-13 |
| ZA200404147B (en) | 2005-06-21 |
| MY141579A (en) | 2010-05-14 |
| RU2318807C2 (ru) | 2008-03-10 |
| TW200306178A (en) | 2003-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5590896A2 (es) | Compuestos quimicos | |
| PE20060286A1 (es) | Derivados de piperidina o piperazina como antagonistas del receptor cgrp | |
| DK162387C (da) | Methacrylsyrederivater af tricyclodecaner, deres fremstilling og anvendelse paa dentalomraadet samt tandfyldningsmasser | |
| NO994115L (no) | Nye 1,4-diazacykloheptanderivater og deres anvendelse i haaroksydasjonsfargestoffer | |
| FI861995A0 (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-(4-benzoyl-1-piperidinyl)-1 -fenylalkanolderivat. | |
| NO20022125L (no) | Pyrrolderivater som inhibitorer for fosfodiesterase VII | |
| ES2086326T3 (es) | Metodo para intensificar la quimiluminiscencia. | |
| FI864618A0 (fi) | Nya 3-oxadiazol- och 3-karboksylsyra- -karbolinderivat, deras framstaellning och deras anvaendning som laekemedel. | |
| DK164554C (da) | 3-vinyl- og 3-ethynyl-beta-carbolinderivater og fremgangsmaade til fremstilling heraf | |
| DK288287D0 (da) | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande | |
| PT90912A (pt) | Processo para a preparacao de derivados de tiofenol | |
| DK337883A (da) | Fremgangsmaade til fremstilling af muramylpeptider eller salte deraf | |
| DE3876402D1 (de) | N-(2-alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid-derivate und deren verwendung als kollagenase-inhibitoren. | |
| ES8304945A1 (es) | "un procedimiento para la preparacion de pirimidin-2-onas sustituidas". | |
| ES2191422T3 (es) | N-sulfonil y n-sulfinil fenilglicinamida. | |
| DK176085A (da) | 4-(nitrophenyl)-tetrahydropyridiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
| FI931688A0 (fi) | Benzoxazinon- och benzotiazinonderivat med effekt pao hjaertblodkaerlen | |
| DE3371512D1 (en) | Substituted pyrimidin-2-ones and the salts thereof | |
| DK32287A (da) | 3-acylaminomethyl-imidazo(1,2-a)pyridinderivater, fremgangsmaade til fremstilling deraf samt laegemiddel indeholdende saadanne derivater | |
| MX173421B (es) | Imidazobenzodiazepinas y sus sales y procedimiento para su preparacion | |
| DK72383D0 (da) | Substituerede oximinoacetanilider, fremgangsmader til fremstilling deraf samt deres anvendelse som midler til bekaempelse af skadelige organismer | |
| DK628486D0 (da) | Pyranderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse | |
| CO4950546A1 (es) | Compuestos | |
| DK11184A (da) | Amidderivater | |
| ECSP982664A (es) | Nuevos derivados de 2- (3h) oxazolona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |